ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,064 | -20.3% | 1,354,541 | -0.6% | 0.01% | 0.0% |
| Q2 2023 | $5,099 | +109.1% | 1,363,382 | +87.4% | 0.01% | +133.3% |
| Q1 2023 | $2,438 | -18.3% | 727,700 | +17.3% | 0.00% | -25.0% |
| Q4 2022 | $2,985 | -99.9% | 620,600 | +3.9% | 0.00% | -20.0% |
| Q3 2022 | $3,399,000 | -27.8% | 597,400 | -9.9% | 0.01% | -16.7% |
| Q2 2022 | $4,707,000 | -44.0% | 663,000 | -43.1% | 0.01% | -40.0% |
| Q1 2022 | $8,411,000 | +51.5% | 1,165,000 | +87.7% | 0.01% | +42.9% |
| Q4 2021 | $5,550,000 | +600.8% | 620,800 | +2646.9% | 0.01% | +600.0% |
| Q3 2021 | $792,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |